J. Paul Abernathy - 07 May 2026 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Reporting relationship: Director
Issuer ticker: NHC
Reported as of: 07 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 May 2026, 18:09:02 UTC
Prior SEC filing: 10 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ J. Paul Abernathy

Key filing fact

J. Paul Abernathy filed Form 4 for NATIONAL HEALTHCARE CORP (NHC) on 07 May 2026.

Key facts

This page summarizes J. Paul Abernathy's Form 4 filing for NATIONAL HEALTHCARE CORP (NHC).
1 reported transaction and 4 derivative rows are listed below.
Accepted by SEC: 07 May 2026, 18:09.

Change

Previous filing in this sequence was filed on 10 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001261687 Primary reporting owner

ABERNATHY JAMES PAUL

Relationship: Director
Address: 1523 MIRABELLA WAY, MURFREESBORO
Signature: /s/ J. Paul Abernathy
Signature date: 07 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NHC holding

Shares of Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 43,302
Date: 07 May 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NHC transaction Derivative

Option to Purchase Common Stock [2026 Grant]

Award

Transaction value
Shares: +7,500
Change %
Price: $0.000000^*
Shares after: 7,500
Date: 07 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,500
Exercise price: $171.42
Footnotes: F1

NHC holding Derivative

Option to Purchase Common Stock [2023 Grant]

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 4,360
Date: 07 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,360
Exercise price: $55.75

NHC holding Derivative

Option to Purchase Common Stock [2024 Grant]

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 7,500
Date: 07 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,500
Exercise price: $96.03

NHC holding Derivative

Option to Purchase Common Stock [2025 Grant]

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 7,500
Date: 07 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,500
Exercise price: $94.66

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).